Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Q46611126)

From Wikidata

Jump to navigation Jump to search

scientific article published in September 2005

Language	Label	Description	Also known as
English	Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia	scientific article published in September 2005

Statements

scholarly article

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16034462

Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (English)

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16034462

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Lee KH

1

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16034462

Lee JH

2

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16034462

Choi SJ

3

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16034462

Lee JH

4

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16034462

Seol M

5

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16034462

Lee YS

6

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16034462

Kim WK

7

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16034462

Lee JS

8

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16034462

Seo EJ

9

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16034462

Jang S

10

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16034462

Park CJ

11

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16034462

Chi HS

12

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16034462

publication date

1 September 2005

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16034462

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16034462

19

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16034462

9

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16034462

1509-1516

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16034462

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403886

0 references

Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403886

21 January 2018

The Outcome of Philadelphia Chromosome-Positive Adult ALL: Characteristics and Prognosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403886

21 January 2018

Philadelphia-chromosome-positive adult acute lymphocytic leukemia: characteristics, treatment results, and prognosis in 41 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403886

21 January 2018

The Philadelphia Chromosome (Ph1) in Adults Presenting with Acute Leukaemia: a Comparison of Ph1+ and Ph1- Patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403886

21 January 2018

Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403886

21 January 2018

The Medical Research Council trials in adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403886

21 January 2018

Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403886

21 January 2018

Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403886

21 January 2018

Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403886

21 January 2018

Predictors of relapse and overall survival in Philadelphia chromosome-positive acute lymphoblastic leukemia after transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403886

21 January 2018

Bone marrow transplant in Ph+ ALL patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403886

21 January 2018

Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403886

21 January 2018

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403886

21 January 2018

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403886

21 January 2018

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403886

21 January 2018

Targeted therapies in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403886

21 January 2018

A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403886

21 January 2018

Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403886

21 January 2018

Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403886

21 January 2018

The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403886

21 January 2018

High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome-positive chronic phase chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403886

21 January 2018

Central nervous system failure in patients with chronic myelogenous leukemia lymphoid blast crisis and Philadelphia chromosome positive acute lymphoblastic leukemia treated with imatinib (STI-571).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403886

21 January 2018

Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403886

21 January 2018

Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403886

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of BCR-ABL and E2A-PBX1 fusion genes by RT-PCR in acute lymphoblastic leukaemia with failed or normal cytogenetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403886

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2403886

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16034462

release_rfdaid3i7jdazg2owx5hk5aoxu

1 reference

https://api.fatcat.wiki/v0/release/rfdaid3i7jdazg2owx5hk5aoxu

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16034462

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46611126&oldid=2122195304"